Chronic Migraine
Chronic migraine is defined by the ICHD-3 as headache occurring on 15 or more days per month for …
Read articleClinical Library
Headache disorder clinical reference.
Evidence-based explainers on headache disorder treatments, drug classes, and mechanisms. Free, no account required.
OnabotulinumtoxinA (Botox) for Chronic Migraine
OnabotulinumtoxinA (Botox) is FDA-approved for chronic migraine prevention (≥15 headache days/mon…
Read articleCGRP Monoclonal Antibodies
First-in-class preventive therapies designed specifically for migraine. Available as Aimovig (ere…
Read articleGepants (CGRP Receptor Antagonists)
A newer class of migraine treatments that block the CGRP receptor. Available as Nurtec ODT (rimeg…
Read articleTriptans
The most widely used class of prescription acute migraine treatments. Seven triptans are availabl…
Read articleMedication Overuse Headache
A common but underdiagnosed complication of frequent acute medication use. MOH affects an estimat…
Read articleMigraine Burden and Prevalence
Migraine affects an estimated 39-40 million people in the United States and approximately 1 billi…
Read articleEpisodic to Chronic Migraine Progression
Approximately 2.5% of people with episodic migraine progress to chronic migraine each year. Risk …
Read articleHeadache Specialist Shortage
There are approximately 900 UCNS-certified headache medicine specialists in the United States — p…
Read articleAdequate Treatment Rate in Migraine
Studies consistently show that a large majority of people with migraine are not receiving adequat…
Read articlePayer Policy Barriers in Migraine
Prior authorization requirements, step therapy mandates, and formulary restrictions create substa…
Read articleMore topics coming soon — including episodic migraine, CGRP mechanism, and preventive therapy.
Looking for PA guidance? The PA Engine covers 1,205 payers across all 50 states — free for every clinician, no account required.
Run a PA — free